Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosis


Min M., Spelman T., Lugaresi A., BOZ C., Spitaleri D. L. A., Pucci E., ...More

MULTIPLE SCLEROSIS JOURNAL, vol.24, no.12, pp.1569-1577, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 12
  • Publication Date: 2018
  • Doi Number: 10.1177/1352458518798147
  • Journal Name: MULTIPLE SCLEROSIS JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1569-1577
  • Keywords: Disease-modifying therapy, magnetic resonance imaging, subclinical lesions, MAGNIMS CONSENSUS GUIDELINES, MS, RECOMMENDATIONS, PERFORMANCE, IMPAIRMENT, DISABILITY, DIAGNOSIS
  • Karadeniz Technical University Affiliated: Yes

Abstract

Background: The current best practice suggests yearly magnetic resonance imaging (MRI) to monitor treatment response in multiple sclerosis (MS) patients.